JP2005002129A5 - - Google Patents

Download PDF

Info

Publication number
JP2005002129A5
JP2005002129A5 JP2004225107A JP2004225107A JP2005002129A5 JP 2005002129 A5 JP2005002129 A5 JP 2005002129A5 JP 2004225107 A JP2004225107 A JP 2004225107A JP 2004225107 A JP2004225107 A JP 2004225107A JP 2005002129 A5 JP2005002129 A5 JP 2005002129A5
Authority
JP
Japan
Prior art keywords
treatment
benzyloxycarbonyl
amino
use according
tetrahydrothieno
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004225107A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005002129A (ja
Filing date
Publication date
Priority claimed from US08/959,758 external-priority patent/US5939432A/en
Priority claimed from US09/156,077 external-priority patent/US6323214B1/en
Application filed filed Critical
Publication of JP2005002129A publication Critical patent/JP2005002129A/ja
Publication of JP2005002129A5 publication Critical patent/JP2005002129A5/ja
Pending legal-status Critical Current

Links

JP2004225107A 1997-10-29 2004-08-02 アロステリックアデノシン受容体修飾物質 Pending JP2005002129A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/959,758 US5939432A (en) 1997-10-29 1997-10-29 Thiophenes useful for modulating the adenosine receptor
US09/156,077 US6323214B1 (en) 1997-10-29 1998-09-17 Allosteric adenosine receptor modulators

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2000517772A Division JP2003517429A (ja) 1997-10-29 1998-09-30 アロステリックアデノシン受容体修飾物質

Publications (2)

Publication Number Publication Date
JP2005002129A JP2005002129A (ja) 2005-01-06
JP2005002129A5 true JP2005002129A5 (https=) 2005-11-17

Family

ID=25502368

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000517772A Pending JP2003517429A (ja) 1997-10-29 1998-09-30 アロステリックアデノシン受容体修飾物質
JP2004225107A Pending JP2005002129A (ja) 1997-10-29 2004-08-02 アロステリックアデノシン受容体修飾物質

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2000517772A Pending JP2003517429A (ja) 1997-10-29 1998-09-30 アロステリックアデノシン受容体修飾物質

Country Status (7)

Country Link
US (3) US5939432A (https=)
EP (1) EP1025106B1 (https=)
JP (2) JP2003517429A (https=)
AT (1) ATE330959T1 (https=)
AU (1) AU9671798A (https=)
CA (1) CA2302396C (https=)
WO (1) WO1999021617A2 (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6727258B2 (en) * 1997-10-29 2004-04-27 King Pharmaceutical Research & Development, Inc. Allosteric adenosine receptor modulators
DE19947154A1 (de) * 1999-10-01 2001-10-04 Bayer Ag Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
JP4548882B2 (ja) * 1999-11-30 2010-09-22 興和創薬株式会社 ４，５，６，７−テトラヒドロチエノ〔２，３−ｃ〕ピリジン化合物
JP4502435B2 (ja) * 1999-11-30 2010-07-14 興和創薬株式会社 ４，５，６，７−テトラヒドロチエノ〔２，３−ｃ〕ピリジン系化合物
JP4548884B2 (ja) * 1999-12-03 2010-09-22 興和創薬株式会社 ４，５，６，７−テトラヒドロチエノ〔２，３−ｃ〕ピリジン誘導体
US7732484B2 (en) * 2000-08-01 2010-06-08 University Of Virginia Patent Foundation Use of selective adenosine A1 receptor allosteric enhancers to manipulate angiogenesis
US6248774B1 (en) * 2000-09-05 2001-06-19 King Pharmaceuticals Research & Development, Inc. Method for treating hyper-excited sensory nerve functions in humans
US6489356B2 (en) * 2000-09-05 2002-12-03 Edward Leung Method for treating pain in humans
GB0100620D0 (en) * 2001-01-10 2001-02-21 Vernalis Res Ltd Chemical cokpounds V
GB0100621D0 (en) 2001-01-10 2001-02-21 Vernalis Res Ltd Chemical compounds VI
GB0100624D0 (en) 2001-01-10 2001-02-21 Vernalis Res Ltd Chemical compounds VII
GB0100622D0 (en) * 2001-01-10 2001-02-21 Vernalis Res Ltd Chemical compounds V111
US20020115635A1 (en) * 2001-02-21 2002-08-22 Pnina Fishman Modulation of GSK-3beta activity and its different uses
ES2365905T3 (es) * 2001-03-30 2011-10-13 King Pharmaceuticals, Inc. Compuestos de tiofeno condensados y uso de los mismos en el tratamiento del dolor crónico.
US6713638B2 (en) * 2001-05-18 2004-03-30 Joel M. Linden 2-amino-3-aroyl-4,5 alkylthiophenes: agonist allosteric enhancers at human A1 adenosine receptors
PL370980A1 (en) * 2001-12-12 2005-06-13 F.Hoffmann-La Roche Ag Benzothiophenes as adenosine receptor modulators
JP2005529846A (ja) * 2002-01-16 2005-10-06 ユニバーシティ オブ バージニア パテント ファウンデーション Ａ１アデノシン受容体の２−アミノチアゾールアロステリックエンハンサ
US20040121406A1 (en) * 2002-05-23 2004-06-24 Wilson Constance Neely Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
US7674791B2 (en) 2003-04-09 2010-03-09 Biogen Idec Ma Inc. Triazolopyrazines and methods of making and using the same
WO2004092173A2 (en) 2003-04-09 2004-10-28 Biogen Idec Ma Inc. A2a adenosine receptor antagonists
EP1615930A2 (en) 2003-04-09 2006-01-18 Biogen Idec MA, Inc. Triazolotriazines and pyrazolotriazines useful as a2a adenosine receptor antagonists
US8062272B2 (en) * 2004-05-21 2011-11-22 Bluesky Medical Group Incorporated Flexible reduced pressure treatment appliance
KR20090112627A (ko) * 2006-11-13 2009-10-28 킹 파머슈티칼스 리서치 앤드 디벨로프먼트 아이엔씨 에이1 아데노신 수용체의 알로스테릭 조절제
US7855209B2 (en) * 2006-11-13 2010-12-21 King Pharmaceuticals Research And Development, Inc. Allosteric modulators of the A1 adenosine receptor
US7897596B2 (en) * 2006-11-13 2011-03-01 King Pharmaceuticals Research & Development, Inc. Allosteric modulators of the A1 adenosine receptor
PA8801401A1 (es) * 2007-10-25 2009-05-15 Janssen Pharmaceutica Nv Arilindenopirimidinas y su uso como adenosina a2a
GB0722340D0 (en) * 2007-11-14 2007-12-27 Univ Leiden Sphingosine-1-phosphate (S1P) receptor compounds
US20090281145A1 (en) * 2008-05-08 2009-11-12 Pier Giovanni Baraldi Allosteric enhancers of the a1 adenosine receptor
GB0906579D0 (en) 2009-04-16 2009-05-20 Vernalis R&D Ltd Pharmaceuticals, compositions and methods of making and using the same
US20100093763A1 (en) * 2008-10-13 2010-04-15 Barbay J Kent PHENYL SUBSTITUTED THIENO[2,3-d]PYRIMIDINES AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
US20100093702A1 (en) * 2008-10-13 2010-04-15 Barbay J Kent METHYLENE AMINES OF THIENO[2,3-d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
US20100093714A1 (en) * 2008-10-13 2010-04-15 Devraj Chakravarty AMIDES OF THIENO[2,3-d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
WO2011010306A1 (en) 2009-07-21 2011-01-27 Ramot At Tel-Aviv University Ltd. A3 adenosine receptor ligands for modulation of pigmentation
ES2974634T3 (es) 2018-12-21 2024-06-28 Celgene Corp Inhibidores de tienopiridinas de RIPK2

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH540247A (de) * 1967-04-21 1973-09-28 Ciba Geigy Ag Verfahren zur Herstellung von heterocyclischen, Asthylendoppelbindungen enthaltenden Verbindungen
ES393101A1 (es) * 1971-07-09 1974-05-16 Made Labor Sa Procedimiento para la preparacion de derivados de tieno- diazepina.
FI54312C (fi) * 1972-05-09 1978-11-10 Sumitomo Chemical Co Foerfarande foer framstaellning av tieno-(2,3-d)pyrimidinderivat med avsoendring av urinsyra i urin utoekande
JPS5342400B2 (https=) 1973-05-30 1978-11-10
PH30676A (en) 1986-07-22 1997-09-16 Boehringer Ingelhein Kg Hetrazepine compounds which have useful pharmaceutical utility
CH677511A5 (https=) * 1988-10-12 1991-05-31 Mefina Sa
US5026698A (en) 1988-11-02 1991-06-25 Nissan Chemical Industries, Ltd. Thienopyridine type mevalonolactones
YU133090A (sh) * 1989-07-12 1993-10-20 Boehringer Ingelheim Kg. Novi heteroazepini s paf-antaganostičnim učinkom in postopek za njihovo pripravo
EP0638560A4 (en) 1991-10-11 1995-03-29 Yoshitomi Pharmaceutical MEDICINE FOR OSTEOPOROSIS AND DIAZEPINE COMPOUND *.
JPH05345785A (ja) * 1992-01-16 1993-12-27 Yoshitomi Pharmaceut Ind Ltd トリアゾロオキサゼピン化合物
TW263498B (https=) * 1993-11-10 1995-11-21 Takeda Pharm Industry Co Ltd
JPH07304755A (ja) * 1994-05-12 1995-11-21 Yamanouchi Pharmaceut Co Ltd 縮合ジアゼピン誘導体
EP0791000B1 (en) * 1994-11-08 2002-10-02 Takeda Chemical Industries, Ltd. Thienopyridine or thienopyrimidine derivatives and their use
US5585538A (en) 1995-03-08 1996-12-17 Pioneer Hi-Bred International, Inc. Hybrid maize plant & seed (3936)
JPH08337583A (ja) 1995-04-13 1996-12-24 Takeda Chem Ind Ltd 複素環化合物およびその製造法
US5757486A (en) * 1996-11-22 1998-05-26 Eastman Kodak Company Digital camera image sensor positioning apparatus including a non-coherent light interferometer

Similar Documents

Publication Publication Date Title
JP2005002129A5 (https=)
RU2328283C2 (ru) Лечение диабета типа 2 ингибиторами дипептидилпептидазы iv
KR101733247B1 (ko) 외상 후 스트레스 장애를 치료하기 위한 테트라하이드로퀴놀린 유도체
RU2009114857A (ru) Гетероциклические органические соединения
JP2010530431A5 (https=)
JP6232184B2 (ja) 神経伝導速度改善のための方法および組成物
SK75999A3 (en) 3-pyridyl enantiomers and their use as analgesics
RU2010107284A (ru) Производные нафтиридина в качестве модуляторов калиевых каналов
US6995148B2 (en) Adenosine cyclic ketals: novel adenosine analogues for pharmacotherapy
JP7137650B2 (ja) テトラヒドロイソキノリン誘導体
EP1833804A1 (en) Aryl sulphonamide modulators
JP2005526696A5 (https=)
EA019037B1 (ru) 5-[5-[2-[3,5-бис(трифторметил)фенил-2-метилпропаноилметиламино]-4-(4-фтор-2-метилфенил)]-2-пиридинил]-2-алкилпролинамиды в качестве антагонистов рецептора nk1
JP6693520B2 (ja) ピペラジン誘導体
JP2009515877A (ja) Ｃｎｓ障害を処置するための組成物および方法
CN1085979C (zh) 麻药型镇痛剂依赖性/抗性形成抑制剂
KR20080091366A (ko) 트리아진 유도체 및 인슐린 분비 자극제의 조합물
US6403575B1 (en) 3-Pyridyl enantiomers and their use as analgesics
SK1912004A3 (en) Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome
TWI285110B (en) Parkinson disease therapeutic agent
JP2012514638A (ja) 新生物障害のための組み合わせ療法
EP3027190A1 (en) Compound and methods for treating long qt syndrome
Orito et al. Mechanisms of action of OPC-28326, a selective hindlimb vasodilator
JP5583325B2 (ja) イオンチャネル調節化合物の投与レジメ
JP2005526026A5 (https=)